...
首页> 外文期刊>Cancer Cell >Th9 Cells Represent a Unique Subset of CD4(+) T Cells Endowed with the Ability to Eradicate Advanced Tumors
【24h】

Th9 Cells Represent a Unique Subset of CD4(+) T Cells Endowed with the Ability to Eradicate Advanced Tumors

机译:TH9细胞代表CD4(+)T细胞的独特子集,赋予了根除晚期肿瘤的能力

获取原文
获取原文并翻译 | 示例
           

摘要

The antitumor effector T helper 1 (Th1) and Th17 cells represent two T cell paradigms: short-lived cytolytic Th1 cells and "stem cell-like'' memory Th17 cells. We report that Th9 cells represent a third paradigmthey are less-exhausted, fully cytolytic, and hyperproliferative. Only tumor-specific Th9 cells completely eradicated advanced tumors, maintained a mature effector cell signature with cytolytic activity as strong as Th1 cells, and persisted as long as Th17 cells in vivo. Th9 cells displayed a unique Pu. 1-Traf6-NF-kappa B activation-driven hyperproliferative feature, suggesting a persistence mechanism rather than an antiapoptotic strategy. Th9 antitumor efficacy depended on interleukin-9 and upregulated expression of Eomes and Traf6. Thus, tumor-specific Th9 cells are a more effective CD4(+) T cell subset for adoptive cancer therapy.
机译:抗肿瘤效应器T辅助辅助辅助剂1(TH1)和TH17细胞代表两种T细胞范式:短寿命的细胞分解TH1细胞和“干细胞状”记忆TH17细胞。我们报告说TH9细胞代表第三个PARADIGMTHEY少耗尽, 完全cytolytic,且过度增殖性。只有肿瘤特异性Th9细胞完全消除先进的肿瘤,将具有Cytolytic活性的成熟效应细胞特征与Th1细胞具有强,并且只要体内的Th17细胞持续存在。1 -Traf6-NF-Kappa B激活驱动的过度增强特征,表明持久性机制而不是抗污染策略。TH9抗肿瘤功效依赖于白细胞介素-9和eomes和TRAF6的上调表达。因此,肿瘤特异性TH9细胞是更有效的 CD4(+)T细胞子集,用于收养癌症疗法。

著录项

  • 来源
    《Cancer Cell》 |2018年第6期|共20页
  • 作者单位

    Wake Forest Sch Med Dept Microbiol &

    Immunol Winston Salem NC 27101 USA;

    Cleveland Clin Lerner Res Inst Dept Canc Biol Cleveland OH 44195 USA;

    Wake Forest Sch Med Dept Microbiol &

    Immunol Winston Salem NC 27101 USA;

    Cleveland Clin Lerner Res Inst Dept Canc Biol Cleveland OH 44195 USA;

    Cleveland Clin Lerner Res Inst Dept Canc Biol Cleveland OH 44195 USA;

    Tsinghua Univ Inst Immunol Beijing 100084 Peoples R China;

    Cleveland Clin Lerner Res Inst Dept Canc Biol Cleveland OH 44195 USA;

    Tsinghua Univ Inst Immunol Beijing 100084 Peoples R China;

    Cleveland Clin Lerner Res Inst Dept Canc Biol Cleveland OH 44195 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号